AGO2 and prostate carcinoma: circSPIRE1 exhibited only weak binding affinity with Argonaute 2 (AGO2), indicating that circSPIRE1 is unlikely to exert its biological effects in prostate cancer through the miRNA sponge mechanism (Fig. 3A).